JP2023554391A5 - - Google Patents
Info
- Publication number
- JP2023554391A5 JP2023554391A5 JP2023536389A JP2023536389A JP2023554391A5 JP 2023554391 A5 JP2023554391 A5 JP 2023554391A5 JP 2023536389 A JP2023536389 A JP 2023536389A JP 2023536389 A JP2023536389 A JP 2023536389A JP 2023554391 A5 JP2023554391 A5 JP 2023554391A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- alkylene
- alkoxy
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063126364P | 2020-12-16 | 2020-12-16 | |
| US63/126,364 | 2020-12-16 | ||
| PCT/US2021/063724 WO2022133040A1 (en) | 2020-12-16 | 2021-12-16 | Kinase inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023554391A JP2023554391A (ja) | 2023-12-27 |
| JP2023554391A5 true JP2023554391A5 (https=) | 2024-12-24 |
Family
ID=79425572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023536389A Pending JP2023554391A (ja) | 2020-12-16 | 2021-12-16 | キナーゼ阻害剤およびそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240083844A1 (https=) |
| EP (1) | EP4263501A1 (https=) |
| JP (1) | JP2023554391A (https=) |
| KR (1) | KR20230144529A (https=) |
| CN (1) | CN117083265A (https=) |
| AU (1) | AU2021401282A1 (https=) |
| CA (1) | CA3179325A1 (https=) |
| MX (1) | MX2023006434A (https=) |
| WO (1) | WO2022133040A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116356017A (zh) * | 2022-12-12 | 2023-06-30 | 南京腾辰生物科技有限公司 | 一种甲状腺肿瘤良恶性早期诊断标志物及其应用 |
| WO2025184877A1 (zh) * | 2024-03-07 | 2025-09-12 | 中国医学科学院基础医学研究所 | 新免疫检查点grhl3在癌症诊疗和免疫治疗疗效评价中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200703912B (en) * | 2004-10-20 | 2008-09-25 | Serono Lab | 3-arylamino pyridine derivatives |
| GB0812913D0 (en) * | 2008-07-15 | 2008-08-20 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| CN102666512B (zh) * | 2009-10-13 | 2014-11-26 | 奥斯特姆医疗公司 | 对疾病治疗有用的mek抑制剂 |
| WO2012055953A1 (en) * | 2010-10-29 | 2012-05-03 | Bayer Pharma Aktiengesellschaft | Substituted phenoxypyridines |
| AU2013266438B2 (en) * | 2012-05-22 | 2017-09-07 | The University Of North Carolina At Chapel Hill | Pyrimidine compounds for the treatment of cancer |
| WO2019006548A1 (en) * | 2017-07-04 | 2019-01-10 | Trillium Therapeutics Inc. | FLUORINATED 2,4-DIAMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF TYROSINE KINASE MER (MERTK) AND USES THEREOF |
-
2021
- 2021-12-16 AU AU2021401282A patent/AU2021401282A1/en active Pending
- 2021-12-16 WO PCT/US2021/063724 patent/WO2022133040A1/en not_active Ceased
- 2021-12-16 US US18/266,793 patent/US20240083844A1/en active Pending
- 2021-12-16 MX MX2023006434A patent/MX2023006434A/es unknown
- 2021-12-16 EP EP21841148.6A patent/EP4263501A1/en active Pending
- 2021-12-16 CA CA3179325A patent/CA3179325A1/en active Pending
- 2021-12-16 JP JP2023536389A patent/JP2023554391A/ja active Pending
- 2021-12-16 CN CN202180084903.0A patent/CN117083265A/zh active Pending
- 2021-12-16 KR KR1020237024086A patent/KR20230144529A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2754808C (en) | Prodrug forms of kinase inhibitors and their use in therapy | |
| US10100034B2 (en) | Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts | |
| JP2024522766A5 (https=) | ||
| WO2021168193A1 (en) | Pyridopyrimidine derivatives as kras inhibitors | |
| EP2253625B1 (en) | Pyridazinones, the preparation and the use thereof | |
| JP2023520333A5 (https=) | ||
| JP7738550B2 (ja) | Ｅｒｋ１およびｅｒｋ２の複素環式阻害剤の使用のための改善された方法、キット、組成物、ならびに投与レジメン | |
| PL206627B1 (pl) | Pochodna chinazoliny, jej zastosowanie i kompozycja farmaceutyczna | |
| JP2010539095A5 (https=) | ||
| RU2006122853A (ru) | Производные диарилмочевины для лечения заболеваний, зависимых от протеинкиназы | |
| JP2023554391A5 (https=) | ||
| WO2021249234A1 (zh) | 苯并噻唑类衍生物及其用途 | |
| JP2020534373A5 (https=) | ||
| CN104736155A (zh) | 双环化合物作为激酶的抑制剂 | |
| JP7419503B2 (ja) | 置換フェニル又はピリジニル部分を有するｓｅｒｄ三環化合物の製造方法 | |
| CN104910140A (zh) | 喹唑啉类化合物、其制备方法及应用 | |
| JP2024531670A (ja) | 塩素化テトラリン化合物及び医薬組成物 | |
| JP2007532658A (ja) | がんの治療方法 | |
| JP2017137323A (ja) | 新規抗がん剤 | |
| CN103965175B (zh) | 4‑(取代苯氨基)喹唑啉类化合物、其制备方法及应用 | |
| WO2016127085A1 (en) | hTRPV1 CHEMICAL AGENTS | |
| CN101671301A (zh) | 杂环取代的二苯脲类衍生物及其用途 | |
| JP2022521474A5 (https=) | ||
| CN102272126B (zh) | 光学纯喹唑啉类化合物 | |
| CN102344444B (zh) | 光学纯喹唑啉类化合物 |